LINAGLIPTIN

LINAGLIPTIN was reported 18486 times

LINAGLIPTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 394 0.7061
1 IMMUNISATION 257 0.5922
2 PALMOPLANTAR KERATODERMA 388 0.5352
3 5-HYDROXYINDOLACETIC ACID INCREASED 20 0.3077
4 BLOOD MERCURY ABNORMAL 28 0.2857
5 URETHRAL CARUNCLE 18 0.2687
6 CYSTOSTOMY 14 0.2500
7 PULMONARY VALVE DISEASE 25 0.1923
8 ATRIAL TACHYCARDIA 396 0.1884
9 PRURITUS GENITAL 393 0.1667
10 URETERIC HAEMORRHAGE 11 0.1594
11 HEPATOJUGULAR REFLUX 22 0.1325
12 NEUROGLYCOPENIA 13 0.1182
13 CAROTID ARTERY OCCLUSION 399 0.1093
14 ELECTROCARDIOGRAM Q WAVE ABNORMAL 22 0.0940
15 SLEEP TERROR 387 0.0918
16 TENSION HEADACHE 392 0.0911
17 PERITONEAL HAEMATOMA 10 0.0667
18 FIBROUS HISTIOCYTOMA 23 0.0655
19 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 23 0.0588
20 PHYSICAL EXAMINATION ABNORMAL 22 0.0574
21 PANCREATITIS HAEMORRHAGIC 26 0.0560
22 SUBARACHNOID HAEMORRHAGE 450 0.0441
23 FACIAL PAIN 391 0.0438
24 OCCULT BLOOD 22 0.0419
25 INSULIN-LIKE GROWTH FACTOR DECREASED 21 0.0397
26 VASCULITIS 399 0.0342
27 PEMPHIGOID 258 0.0342
28 DERMATITIS BULLOUS 235 0.0324
29 BITE 20 0.0277
30 ANOSMIA 392 0.0271
31 PERIPHERAL CIRCULATORY FAILURE 11 0.0268
32 VENTRICULAR TACHYCARDIA 432 0.0261
33 ATROPHIC VULVOVAGINITIS 18 0.0246
34 ALBUMINURIA 13 0.0243
35 HEART FAILURE WITH REDUCED EJECTION FRACTION 13 0.0243
36 PERICARDITIS 398 0.0237
37 CAROTID ARTERIOSCLEROSIS 24 0.0233
38 SYSTOLIC DYSFUNCTION 22 0.0209
39 LOW DENSITY LIPOPROTEIN DECREASED 29 0.0205
40 EUGLYCAEMIC DIABETIC KETOACIDOSIS 84 0.0203
41 HELICOBACTER GASTRITIS 24 0.0194
42 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 20 0.0188
43 LIGHT CHAIN ANALYSIS INCREASED 19 0.0184
44 NEPHROGENIC ANAEMIA 80 0.0173
45 MUSCLE TWITCHING 396 0.0172
46 HYPERPARATHYROIDISM SECONDARY 43 0.0171
47 LEFT ATRIAL DILATATION 21 0.0165
48 HYPERLACTACIDAEMIA 44 0.0164
49 APRAXIA 24 0.0162
50 ECHOCARDIOGRAM ABNORMAL 22 0.0157
51 DIPLOPIA 395 0.0152
52 BRONCHITIS VIRAL 10 0.0149
53 MULTIPLE DRUG THERAPY 11 0.0146
54 PAIN OF SKIN 391 0.0145
55 MYCOPLASMA INFECTION 11 0.0141
56 NEOPLASM SKIN 21 0.0135
57 LIP SWELLING 441 0.0132
58 ASTERIXIS 14 0.0132
59 CLOSTRIDIUM TEST POSITIVE 29 0.0131
60 TRANSIENT ISCHAEMIC ATTACK 438 0.0130
61 STENOSIS 24 0.0128
62 RASH PAPULAR 283 0.0126
63 BRONCHIAL HYPERREACTIVITY 15 0.0125
64 GLOMERULONEPHRITIS MEMBRANOUS 14 0.0119
65 EYE PRURITUS 400 0.0119
66 MITRAL VALVE DISEASE 21 0.0119
67 ACUTE LUNG INJURY 14 0.0118
68 GLYCOSYLATED HAEMOGLOBIN INCREASED 298 0.0118
69 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 13 0.0117
70 HYPOVOLAEMIA 67 0.0114
71 HYPOGLYCAEMIC COMA 33 0.0114
72 CARDIAC DISCOMFORT 23 0.0114
73 GLYCOSYLATED HAEMOGLOBIN DECREASED 18 0.0112
74 BLINDNESS 451 0.0111
75 RENAL TUBULAR ACIDOSIS 24 0.0110
76 MUCOSAL DRYNESS 22 0.0109
77 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 13 0.0109
78 ANAEMIA MACROCYTIC 23 0.0108
79 BLOOD SODIUM INCREASED 28 0.0104
80 ANGIOEDEMA 448 0.0101
81 DIABETIC METABOLIC DECOMPENSATION 14 0.0101
82 DIASTOLIC DYSFUNCTION 31 0.0100
83 BLOOD PHOSPHORUS INCREASED 27 0.0099
84 CAROTID ARTERY STENOSIS 34 0.0097
85 HAEMATOCRIT INCREASED 22 0.0096
86 VENTRICULAR ARRHYTHMIA 34 0.0093
87 PERIPHERAL ARTERY OCCLUSION 13 0.0092
88 HEPATIC NEOPLASM 30 0.0092
89 BLOOD CHOLESTEROL DECREASED 17 0.0091
90 RALES 53 0.0091
91 DIABETIC NEPHROPATHY 20 0.0091
92 COGNITIVE DISORDER 422 0.0090
93 VITAMIN B12 DECREASED 26 0.0090
94 TINNITUS 412 0.0090
95 BLOOD GLUCOSE ABNORMAL 165 0.0089
96 BLOOD CHLORIDE DECREASED 23 0.0089
97 DIABETIC FOOT 27 0.0088
98 HYPOGLYCAEMIA 426 0.0088
99 VENTRICULAR HYPOKINESIA 28 0.0087
100 TROPONIN T INCREASED 11 0.0087
101 SHOULDER FRACTURE 14 0.0086
102 LEFT VENTRICULAR DYSFUNCTION 56 0.0084
103 DYSPNOEA AT REST 24 0.0083
104 BUNDLE BRANCH BLOCK LEFT 35 0.0082
105 PERICARDIAL HAEMORRHAGE 18 0.0082
106 SEDATION COMPLICATION 21 0.0082
107 VULVOVAGINAL MYCOTIC INFECTION 31 0.0079
108 GLUCOSE URINE PRESENT 10 0.0079
109 END STAGE RENAL DISEASE 140 0.0077
110 HAEMOGLOBIN INCREASED 35 0.0077
111 DISTURBANCE IN ATTENTION 407 0.0075
112 GASTRIC POLYPS 17 0.0075
113 PANCREATIC ENZYMES INCREASED 11 0.0075
114 LACTIC ACIDOSIS 241 0.0074
115 BLOOD GLUCOSE INCREASED 1385 0.0073
116 REBOUND ACID HYPERSECRETION 22 0.0073
117 BLOOD PARATHYROID HORMONE INCREASED 21 0.0072
118 HYPERKALAEMIA 249 0.0071
119 HYPERGLYCAEMIA 255 0.0070
120 METABOLIC ACIDOSIS 219 0.0068
121 AMNESIA 444 0.0068
122 AORTIC VALVE INCOMPETENCE 29 0.0068
123 GASTROINTESTINAL HYPOMOTILITY 15 0.0066
124 DIABETES MELLITUS INADEQUATE CONTROL 117 0.0066
125 ABNORMAL LOSS OF WEIGHT 45 0.0066
126 IMMUNE-MEDIATED LUNG DISEASE 12 0.0066
127 LEFT VENTRICULAR HYPERTROPHY 28 0.0065
128 JOINT DESTRUCTION 10 0.0064
129 GLOMERULAR FILTRATION RATE DECREASED 79 0.0064
130 VITAMIN B12 DEFICIENCY 26 0.0064
131 PULMONARY FUNCTION TEST ABNORMAL 10 0.0064
132 PROTEIN URINE PRESENT 32 0.0064
133 ENTHESOPATHY 10 0.0064
134 CHOLESTATIC LIVER INJURY 14 0.0063
135 PANCREATITIS 332 0.0063
136 AZOTAEMIA 25 0.0063
137 HALLUCINATION 468 0.0062
138 AORTIC VALVE STENOSIS 11 0.0062
139 CHRONIC KIDNEY DISEASE 466 0.0061
140 CORONARY ARTERY STENOSIS 30 0.0060
141 DIABETIC KETOACIDOSIS 142 0.0059
142 SPUTUM DISCOLOURED 56 0.0059
143 BLOOD CREATINE INCREASED 26 0.0059
144 MONOCYTE COUNT INCREASED 21 0.0058
145 ACUTE KIDNEY INJURY 860 0.0056
146 TACHYCARDIA 493 0.0055
147 OESOPHAGEAL VARICES HAEMORRHAGE 12 0.0055
148 DIABETIC NEUROPATHY 27 0.0054
149 CARDIOMEGALY 67 0.0054
150 ARTERIOSCLEROSIS CORONARY ARTERY 36 0.0054
151 NECROTISING FASCIITIS 19 0.0054
152 DISTRIBUTIVE SHOCK 12 0.0053
153 RESPIRATORY SYMPTOM 15 0.0053
154 CARDIAC FAILURE CHRONIC 22 0.0052
155 TRICUSPID VALVE INCOMPETENCE 41 0.0052
156 ANGIOPATHY 28 0.0050
157 TUBULOINTERSTITIAL NEPHRITIS 93 0.0050
158 TOXIC ENCEPHALOPATHY 25 0.0049
159 DEHYDRATION 658 0.0049
160 NEPHROPATHY 46 0.0049
161 INTENTIONAL PRODUCT MISUSE 431 0.0049
162 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 20 0.0049
163 HEART RATE INCREASED 485 0.0049
164 MUSCULAR WEAKNESS 545 0.0048
165 PYELONEPHRITIS 41 0.0047
166 RHINALGIA 13 0.0047
167 HAEMODYNAMIC INSTABILITY 36 0.0047
168 METABOLIC ENCEPHALOPATHY 14 0.0047
169 AMYLASE INCREASED 17 0.0046
170 BLOOD PRESSURE DIASTOLIC DECREASED 34 0.0046
171 BLOOD LACTIC ACID INCREASED 24 0.0046
172 PALPITATIONS 533 0.0045
173 IMPAIRED GASTRIC EMPTYING 62 0.0045
174 BLOOD IMMUNOGLOBULIN E INCREASED 11 0.0045
175 GANGRENE 27 0.0045
176 STAPHYLOCOCCAL SEPSIS 22 0.0045
177 MIGRAINE 424 0.0044
178 BLOOD GLUCOSE FLUCTUATION 48 0.0044
179 BLOOD POTASSIUM INCREASED 71 0.0044
180 IMMUNE-MEDIATED MYOSITIS 12 0.0043
181 HAEMORRHOIDAL HAEMORRHAGE 21 0.0043
182 PHYSICAL DECONDITIONING 11 0.0043
183 INTENTIONAL PRODUCT USE ISSUE 374 0.0043
184 BLOOD PRESSURE SYSTOLIC INCREASED 83 0.0043
185 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 14 0.0042
186 PANCREATITIS ACUTE 95 0.0042
187 LIPASE INCREASED 32 0.0042
188 HYPOMAGNESAEMIA 58 0.0042
189 VISUAL IMPAIRMENT 515 0.0042
190 KETOACIDOSIS 31 0.0041
191 BLOOD IRON DECREASED 49 0.0041
192 EOSINOPHILIC PNEUMONIA 13 0.0041
193 BILE DUCT STONE 13 0.0041
194 APLASIA PURE RED CELL 14 0.0041
195 STUPOR 13 0.0040
196 HYPERHIDROSIS 521 0.0040
197 PERIPHERAL SWELLING 613 0.0040
198 SUPRAVENTRICULAR TACHYCARDIA 38 0.0040
199 CLOSTRIDIUM DIFFICILE COLITIS 42 0.0040
200 TOE AMPUTATION 20 0.0039
201 HYPERURICAEMIA 16 0.0039
202 FORCED EXPIRATORY VOLUME DECREASED 11 0.0039
203 POTENTIATING DRUG INTERACTION 13 0.0039
204 FLANK PAIN 36 0.0038
205 COMPARTMENT SYNDROME 10 0.0038
206 RENAL FAILURE 509 0.0038
207 BREAST CANCER METASTATIC 41 0.0038
208 BLOOD GLUCOSE DECREASED 183 0.0038
209 RENAL IMPAIRMENT 316 0.0038
210 MITRAL VALVE INCOMPETENCE 42 0.0037
211 BLOOD UREA INCREASED 62 0.0037
212 POLYURIA 30 0.0037
213 URINE OUTPUT DECREASED 32 0.0037
214 VARICES OESOPHAGEAL 11 0.0036
215 MEMORY IMPAIRMENT 498 0.0036
216 HAEMATOCRIT DECREASED 71 0.0036
217 ABDOMINAL DISCOMFORT 599 0.0036
218 PANCREATIC CARCINOMA 102 0.0035
219 JOINT LOCK 10 0.0035
220 ODYNOPHAGIA 21 0.0035
221 PANCREATIC CARCINOMA METASTATIC 10 0.0035
222 DRY SKIN 466 0.0035
223 HYPERVOLAEMIA 17 0.0034
224 COVID-19 599 0.0034
225 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
226 CHEST PAIN 623 0.0034
227 BODY TEMPERATURE DECREASED 33 0.0033
228 KIDNEY TRANSPLANT REJECTION 16 0.0033
229 ELECTROCARDIOGRAM ABNORMAL 26 0.0033
230 MYOCARDIAL INFARCTION 578 0.0033
231 ACUTE MYOCARDIAL INFARCTION 96 0.0033
232 BLOOD PRESSURE DIASTOLIC INCREASED 15 0.0032
233 DIABETIC RETINOPATHY 11 0.0032
234 ATRIOVENTRICULAR BLOCK 25 0.0032
235 GOUT 58 0.0032
236 SUSPECTED SUICIDE 15 0.0032
237 BLOOD CREATININE ABNORMAL 11 0.0032
238 CARDIAC FAILURE 254 0.0032
239 AORTIC STENOSIS 11 0.0032
240 ABDOMINAL PAIN UPPER 647 0.0031
241 SHOCK 72 0.0031
242 PERICARDIAL EFFUSION 72 0.0031
243 EJECTION FRACTION DECREASED 48 0.0031
244 FAILURE TO THRIVE 16 0.0031
245 DRUG LEVEL INCREASED 51 0.0031
246 CHOLANGITIS 19 0.0031
247 PANCREATIC DISORDER 15 0.0030
248 DIABETES MELLITUS 231 0.0030
249 RENAL DISORDER 140 0.0030
250 ATRIOVENTRICULAR BLOCK FIRST DEGREE 13 0.0030
251 RED BLOOD CELL COUNT DECREASED 85 0.0030
252 DYSLIPIDAEMIA 15 0.0030
253 BLOOD CREATININE INCREASED 192 0.0029
254 INCONTINENCE 31 0.0029
255 UROSEPSIS 27 0.0029
256 ARTHRITIS BACTERIAL 12 0.0029
257 PROTEIN TOTAL DECREASED 11 0.0029
258 CONCOMITANT DISEASE AGGRAVATED 18 0.0029
259 DELIRIUM 101 0.0029
260 LEFT VENTRICULAR FAILURE 10 0.0029
261 NOCTURIA 35 0.0029
262 NEOPLASM 33 0.0029
263 HYPOPHAGIA 73 0.0029
264 CARDIAC FAILURE ACUTE 19 0.0028
265 ASPIRATION 31 0.0028
266 BLOOD TRIGLYCERIDES INCREASED 50 0.0028
267 POST PROCEDURAL INFECTION 23 0.0028
268 PULMONARY MASS 42 0.0028
269 MELAENA 62 0.0028
270 WOUND SECRETION 11 0.0028
271 RENAL FUNCTION TEST ABNORMAL 13 0.0028
272 HEPATIC STEATOSIS 52 0.0028
273 BACK PAIN 646 0.0028
274 PARKINSONISM 27 0.0028
275 HYPERLIPIDAEMIA 33 0.0028
276 LYMPHOCYTE COUNT DECREASED 48 0.0027
277 OBSTRUCTIVE AIRWAYS DISORDER 30 0.0027
278 ALOPECIA 521 0.0027
279 INFARCTION 18 0.0026
280 HAEMORRHOIDS 51 0.0026
281 NERVE INJURY 29 0.0026
282 ASPERGILLUS INFECTION 17 0.0026
283 CONCUSSION 20 0.0026
284 PULMONARY CONGESTION 34 0.0026
285 DECUBITUS ULCER 21 0.0026
286 THROMBOTIC MICROANGIOPATHY 25 0.0026
287 RENAL TUBULAR NECROSIS 25 0.0025
288 ARTERIAL OCCLUSIVE DISEASE 20 0.0025
289 PROTEINURIA 48 0.0025
290 HEART RATE ABNORMAL 14 0.0025
291 FAECES DISCOLOURED 54 0.0025
292 LEUKOCYTOSIS 45 0.0025
293 CLOSTRIDIUM DIFFICILE INFECTION 54 0.0025
294 NEUTROPHILIA 14 0.0025
295 PERIPHERAL ISCHAEMIA 10 0.0024
296 CORONARY ARTERY DISEASE 74 0.0024
297 ANURIA 21 0.0024
298 GENERALISED OEDEMA 30 0.0024
299 ORTHOSTATIC HYPOTENSION 42 0.0024
300 NEPHROPATHY TOXIC 27 0.0024
301 DRUG LEVEL ABOVE THERAPEUTIC 11 0.0024
302 DEMENTIA 67 0.0024
303 PNEUMONIA BACTERIAL 22 0.0024
304 BLOOD POTASSIUM DECREASED 72 0.0024
305 IRON DEFICIENCY ANAEMIA 22 0.0024
306 ATELECTASIS 23 0.0024
307 CHOLELITHIASIS 78 0.0024
308 RESPIRATORY RATE INCREASED 21 0.0024
309 RENAL INJURY 70 0.0024
310 FEMORAL NECK FRACTURE 12 0.0023
311 ARTERIOSCLEROSIS 22 0.0023
312 MALNUTRITION 26 0.0023
313 HEART RATE IRREGULAR 52 0.0023
314 BLOOD PRESSURE FLUCTUATION 55 0.0023
315 HAEMATURIA 78 0.0023
316 CHOLECYSTITIS 27 0.0023
317 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20 0.0023
318 LETHARGY 130 0.0023
319 HEPATIC ENCEPHALOPATHY 21 0.0022
320 NEUTROPHIL COUNT INCREASED 23 0.0022
321 FEELING ABNORMAL 538 0.0022
322 SKIN ULCER 58 0.0022
323 HEAD INJURY 71 0.0022
324 THIRST 40 0.0022
325 ACIDOSIS 17 0.0022
326 GAMMA-GLUTAMYLTRANSFERASE INCREASED 49 0.0022
327 BRADYKINESIA 13 0.0022
328 PSYCHOLOGICAL TRAUMA 19 0.0022
329 UPPER GASTROINTESTINAL HAEMORRHAGE 37 0.0022
330 LOW DENSITY LIPOPROTEIN INCREASED 17 0.0022
331 KIDNEY INFECTION 43 0.0022
332 PYREXIA 758 0.0022
333 DIALYSIS 31 0.0022
334 MOVEMENT DISORDER 70 0.0022
335 ONYCHOCLASIS 15 0.0022
336 HYPERKERATOSIS 12 0.0022
337 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
338 TOXIC EPIDERMAL NECROLYSIS 33 0.0022
339 CEREBRAL INFARCTION 53 0.0022
340 NERVE COMPRESSION 20 0.0022
341 LOWER GASTROINTESTINAL HAEMORRHAGE 16 0.0022
342 RHABDOMYOLYSIS 90 0.0022
343 NECROSIS 12 0.0022
344 INSOMNIA 574 0.0022
345 SLEEP APNOEA SYNDROME 41 0.0021
346 ENDOCARDITIS 11 0.0021
347 ADRENAL INSUFFICIENCY 26 0.0021
348 SCIATICA 34 0.0021
349 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
350 CHOLECYSTITIS ACUTE 12 0.0021
351 COVID-19 PNEUMONIA 25 0.0021
352 SKIN ABRASION 10 0.0021
353 SEPTIC SHOCK 92 0.0021
354 INTERNAL HAEMORRHAGE 24 0.0021
355 URINARY TRACT INFECTION 355 0.0021
356 SYNCOPE 208 0.0021
357 VOMITING 976 0.0021
358 HAEMOGLOBIN DECREASED 212 0.0021
359 CARDIAC FAILURE CONGESTIVE 165 0.0021
360 PRURITUS 788 0.0020
361 DIARRHOEA 1322 0.0020
362 ECCHYMOSIS 14 0.0020
363 SKIN LESION 56 0.0020
364 PURPURA 18 0.0020
365 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
366 HYDROCEPHALUS 11 0.0020
367 BLOOD ALBUMIN DECREASED 16 0.0020
368 INTESTINAL OBSTRUCTION 76 0.0020
369 HYPERNATRAEMIA 10 0.0020
370 ANXIETY 571 0.0020
371 LIMB DISCOMFORT 62 0.0020
372 DIZZINESS 997 0.0020
373 EOSINOPHILIA 35 0.0020
374 URINARY INCONTINENCE 59 0.0020
375 TYPE 2 DIABETES MELLITUS 67 0.0020
376 OSTEOMYELITIS 36 0.0020
377 GASTROENTERITIS 29 0.0020
378 OEDEMA PERIPHERAL 242 0.0020
379 INCORRECT PRODUCT ADMINISTRATION DURATION 43 0.0020
380 DUODENAL ULCER 14 0.0020
381 BLISTER 110 0.0020
382 RECTAL HAEMORRHAGE 84 0.0020
383 OEDEMA 106 0.0020
384 SKIN DISORDER 65 0.0019
385 BLOOD PRESSURE DECREASED 129 0.0019
386 HIATUS HERNIA 25 0.0019
387 MUSCLE RIGIDITY 23 0.0019
388 PRE-EXISTING CONDITION IMPROVED 12 0.0019
389 MALAISE 843 0.0019
390 DISSEMINATED INTRAVASCULAR COAGULATION 27 0.0019
391 TACHYPNOEA 26 0.0019
392 ENTEROCOLITIS 11 0.0019
393 BLOOD URIC ACID INCREASED 11 0.0019
394 SENSITIVITY TO WEATHER CHANGE 10 0.0019
395 ORAL CANDIDIASIS 25 0.0019
396 BLINDNESS TRANSIENT 14 0.0019
397 CATARACT 113 0.0019
398 ELECTROLYTE IMBALANCE 22 0.0019
399 RENAL CYST 15 0.0019
400 SOPOR 25 0.0019
401 SUBDURAL HAEMATOMA 27 0.0019
402 BRADYCARDIA 100 0.0019
403 DRUG INTERACTION 299 0.0019
404 NEUROTOXICITY 33 0.0019
405 HYPONATRAEMIA 106 0.0019
406 PNEUMONIA ASPIRATION 47 0.0019
407 DYSPNOEA 1060 0.0019
408 ARTHRALGIA 778 0.0019
409 COMPRESSION FRACTURE 10 0.0019
410 DRUG ERUPTION 33 0.0019
411 JAUNDICE 50 0.0019
412 ANAL ABSCESS 10 0.0019
413 BLOOD MAGNESIUM DECREASED 16 0.0019
414 ATAXIA 22 0.0019
415 NEPHROLITHIASIS 85 0.0019
416 TROPONIN INCREASED 14 0.0018
417 DECREASED APPETITE 426 0.0018
418 CORONARY ARTERY OCCLUSION 25 0.0018
419 ERYTHEMA MULTIFORME 17 0.0018
420 NEUTROPENIC SEPSIS 13 0.0018
421 WALKING AID USER 12 0.0018
422 FOOD ALLERGY 14 0.0018
423 CHOKING SENSATION 10 0.0018
424 MUSCULOSKELETAL CHEST PAIN 28 0.0018
425 CELLULITIS 90 0.0018
426 PRODUCTIVE COUGH 85 0.0018
427 HAEMATOMA 46 0.0018
428 ADVERSE DRUG REACTION 159 0.0018
429 FALL 589 0.0018
430 BACTERAEMIA 21 0.0018
431 SEPSIS 197 0.0018
432 HYPOPHOSPHATAEMIA 13 0.0018
433 HYPOCALCAEMIA 33 0.0017
434 HYPOTENSION 349 0.0017
435 FORMICATION 12 0.0017
436 ELECTROCARDIOGRAM QT PROLONGED 62 0.0017
437 FLUID RETENTION 87 0.0017
438 ANGINA PECTORIS 49 0.0017
439 HAEMOGLOBIN ABNORMAL 11 0.0017
440 PLEURAL EFFUSION 104 0.0017
441 HYPERTRIGLYCERIDAEMIA 10 0.0017
442 ATRIAL FIBRILLATION 166 0.0017
443 HYPOXIA 60 0.0017
444 OSTEOPOROSIS 70 0.0017
445 PULMONARY OEDEMA 76 0.0017
446 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48 0.0017
447 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
448 ANGINA UNSTABLE 11 0.0017
449 DRUG-INDUCED LIVER INJURY 53 0.0017
450 PRESYNCOPE 41 0.0017
451 ANKLE FRACTURE 26 0.0017
452 PRODUCT PRESCRIBING ERROR 40 0.0017
453 CARDIAC PACEMAKER INSERTION 10 0.0017
454 DEPRESSED LEVEL OF CONSCIOUSNESS 66 0.0017
455 ANAL INCONTINENCE 15 0.0017
456 ACUTE RESPIRATORY FAILURE 32 0.0017
457 HUNGER 23 0.0016
458 OESOPHAGITIS 18 0.0016
459 FACIAL PARALYSIS 14 0.0016
460 WHITE BLOOD CELL COUNT INCREASED 63 0.0016
461 MEDICATION ERROR 91 0.0016
462 COLITIS ISCHAEMIC 11 0.0016
463 BLOOD THYROID STIMULATING HORMONE INCREASED 15 0.0016
464 WEIGHT DECREASED 454 0.0016
465 CYTOMEGALOVIRUS INFECTION 27 0.0016
466 BLOOD PRESSURE ABNORMAL 32 0.0016
467 GASTROENTERITIS VIRAL 29 0.0016
468 HYPOTONIA 16 0.0016
469 PEMPHIGUS 20 0.0016
470 MYOCLONUS 19 0.0016
471 PAROSMIA 12 0.0016
472 TOXIC SKIN ERUPTION 16 0.0016
473 LIMB INJURY 43 0.0016
474 BLOOD COUNT ABNORMAL 24 0.0016
475 BLOOD PRESSURE INCREASED 242 0.0016
476 HEPATIC FUNCTION ABNORMAL 59 0.0016
477 HEPATOCELLULAR CARCINOMA 12 0.0016
478 SPINAL COMPRESSION FRACTURE 13 0.0016
479 CYSTITIS 50 0.0016
480 MOTOR DYSFUNCTION 16 0.0016
481 NAUSEA 1241 0.0016
482 PHARYNGEAL OEDEMA 24 0.0016
483 EOSINOPHIL COUNT INCREASED 13 0.0016
484 URINARY RETENTION 52 0.0016
485 SEASONAL ALLERGY 22 0.0016
486 POOR VENOUS ACCESS 16 0.0015
487 BLOOD CHOLESTEROL INCREASED 72 0.0015
488 HEPATIC CIRRHOSIS 29 0.0015
489 HYPERCALCAEMIA 19 0.0015
490 FUNGAL INFECTION 51 0.0015
491 TRANSFUSION 16 0.0015
492 LIGAMENT SPRAIN 15 0.0015
493 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
494 UNRESPONSIVE TO STIMULI 39 0.0015
495 RENAL PAIN 16 0.0015
496 ASPARTATE AMINOTRANSFERASE INCREASED 80 0.0015
497 MYOPATHY 13 0.0015
498 CONSTIPATION 328 0.0015
499 GASTROOESOPHAGEAL REFLUX DISEASE 121 0.0015
500 EYE HAEMORRHAGE 20 0.0015
501 PNEUMONIA 484 0.0015
502 DYSURIA 55 0.0015
503 LOCALISED INFECTION 36 0.0015
504 PULMONARY HYPERTENSION 31 0.0015
505 BLOOD SODIUM DECREASED 28 0.0015
506 STEVENS-JOHNSON SYNDROME 33 0.0015
507 BRONCHIECTASIS 10 0.0015
508 OXYGEN SATURATION DECREASED 83 0.0015
509 ABDOMINAL PAIN 343 0.0015
510 LUNG INFILTRATION 13 0.0015
511 POLLAKIURIA 61 0.0015
512 HICCUPS 12 0.0015
513 INITIAL INSOMNIA 15 0.0015
514 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
515 GASTROINTESTINAL HAEMORRHAGE 122 0.0015
516 HEPATIC FAILURE 44 0.0015
517 ANAEMIA 278 0.0015
518 C-REACTIVE PROTEIN INCREASED 53 0.0015
519 RETCHING 31 0.0015
520 PNEUMONITIS 39 0.0014
521 HAEMODIALYSIS 12 0.0014
522 DEFAECATION URGENCY 10 0.0014
523 JOINT DISLOCATION 15 0.0014
524 WRIST FRACTURE 17 0.0014
525 HOSPICE CARE 14 0.0014
526 FEBRILE NEUTROPENIA 94 0.0014
527 RETINAL DETACHMENT 13 0.0014
528 FATIGUE 1098 0.0014
529 INABILITY TO AFFORD MEDICATION 14 0.0014
530 DIVERTICULUM 10 0.0014
531 GASTRITIS 37 0.0014
532 INTERNATIONAL NORMALISED RATIO INCREASED 40 0.0014
533 PRODUCT SUPPLY ISSUE 10 0.0014
534 PSEUDOMONAS INFECTION 12 0.0014
535 AGRANULOCYTOSIS 26 0.0014
536 HYPOACUSIS 60 0.0014
537 GINGIVAL BLEEDING 19 0.0014
538 ASTHENIA 521 0.0014
539 LACERATION 13 0.0014
540 SMALL INTESTINAL OBSTRUCTION 17 0.0014
541 DRUG LEVEL DECREASED 14 0.0014
542 FLATULENCE 78 0.0014
543 OROPHARYNGEAL PAIN 127 0.0014
544 ILEUS 17 0.0014
545 SPINAL PAIN 16 0.0014
546 INTERSTITIAL LUNG DISEASE 66 0.0014
547 CONFUSIONAL STATE 219 0.0014
548 ARRHYTHMIA 64 0.0014
549 ASPHYXIA 11 0.0013
550 TENDERNESS 14 0.0013
551 MUSCLE ATROPHY 17 0.0013
552 HAEMATEMESIS 34 0.0013
553 PRURITUS GENERALISED 29 0.0013
554 MACULAR DEGENERATION 16 0.0013
555 ACUTE CORONARY SYNDROME 11 0.0013
556 ASCITES 39 0.0013
557 HYPOKALAEMIA 61 0.0013
558 ABSCESS 21 0.0013
559 RASH GENERALISED 34 0.0013
560 GASTRIC HAEMORRHAGE 15 0.0013
561 JOINT SWELLING 157 0.0013
562 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
563 RASH ERYTHEMATOUS 62 0.0013
564 EXPIRED PRODUCT ADMINISTERED 43 0.0013
565 HEADACHE 810 0.0013
566 HYPOALBUMINAEMIA 10 0.0013
567 HYPOTHERMIA 13 0.0013
568 CARDIAC OPERATION 11 0.0013
569 MUSCULOSKELETAL DISCOMFORT 22 0.0013
570 BLINDNESS UNILATERAL 18 0.0013
571 PLATELET COUNT DECREASED 136 0.0013
572 CEREBROVASCULAR ACCIDENT 216 0.0013
573 DYSPNOEA EXERTIONAL 48 0.0013
574 INJECTION SITE NODULE 14 0.0013
575 NEUROPATHY PERIPHERAL 121 0.0013
576 TOXICITY TO VARIOUS AGENTS 214 0.0013
577 RESTLESS LEGS SYNDROME 23 0.0013
578 RIB FRACTURE 26 0.0013
579 GASTRIC ULCER 24 0.0013
580 SKIN DISCOLOURATION 58 0.0013
581 RASH 550 0.0013
582 SINUS CONGESTION 17 0.0013
583 EPISTAXIS 94 0.0013
584 RHINORRHOEA 81 0.0013
585 POLYNEUROPATHY 15 0.0013
586 GROIN PAIN 11 0.0013
587 SPINAL OSTEOARTHRITIS 11 0.0013
588 BLOOD CREATINE PHOSPHOKINASE INCREASED 36 0.0012
589 SKIN INFECTION 14 0.0012
590 ROTATOR CUFF SYNDROME 16 0.0012
591 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65 0.0012
592 BLOOD CALCIUM DECREASED 14 0.0012
593 CHROMATURIA 28 0.0012
594 DIZZINESS POSTURAL 12 0.0012
595 RASH PRURITIC 67 0.0012
596 DEVICE RELATED INFECTION 19 0.0012
597 COELIAC DISEASE 12 0.0012
598 HYPERTENSION 259 0.0012
599 BLOOD BILIRUBIN INCREASED 33 0.0012
600 ACUTE MYELOID LEUKAEMIA 19 0.0012
601 JOINT INJURY 26 0.0012
602 COLON CANCER 18 0.0012
603 DECREASED ACTIVITY 13 0.0012
604 OSTEOARTHRITIS 51 0.0012
605 DYSPHAGIA 114 0.0012
606 ULCER 19 0.0012
607 PRESCRIBED OVERDOSE 23 0.0012
608 TASTE DISORDER 24 0.0012
609 ENCEPHALOPATHY 29 0.0012
610 WOUND 33 0.0012
611 EATING DISORDER 25 0.0012
612 GASTROINTESTINAL DISORDER 105 0.0012
613 CHEST DISCOMFORT 120 0.0012
614 ABDOMINAL DISTENSION 122 0.0012
615 SCAR 20 0.0012
616 RESPIRATORY FAILURE 85 0.0012
617 OFF LABEL USE 1019 0.0012
618 THYROID CANCER 14 0.0012
619 MOBILITY DECREASED 83 0.0012
620 GAIT DISTURBANCE 221 0.0012
621 RESPIRATORY TRACT INFECTION 30 0.0012
622 CARDIOMYOPATHY 17 0.0011
623 WEIGHT FLUCTUATION 12 0.0011
624 PAIN 702 0.0011
625 MYOCARDIAL ISCHAEMIA 13 0.0011
626 ERUCTATION 22 0.0011
627 COLD SWEAT 20 0.0011
628 BODY TEMPERATURE INCREASED 23 0.0011
629 PHARYNGEAL SWELLING 11 0.0011
630 CONTRAINDICATED PRODUCT ADMINISTERED 34 0.0011
631 GALLBLADDER DISORDER 20 0.0011
632 SKIN LACERATION 12 0.0011
633 SPINAL FRACTURE 22 0.0011
634 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
635 METASTASES TO BONE 18 0.0011
636 WHEEZING 65 0.0011
637 COUGH 305 0.0011
638 RASH MACULO-PAPULAR 24 0.0011
639 ORAL HERPES 21 0.0011
640 HEAD DISCOMFORT 19 0.0011
641 RESPIRATORY TRACT CONGESTION 17 0.0011
642 VERTIGO 65 0.0011
643 CARDIAC ARREST 88 0.0011
644 NEEDLE ISSUE 31 0.0011
645 HYPERBILIRUBINAEMIA 11 0.0011
646 DYSSTASIA 31 0.0011
647 MUSCULOSKELETAL STIFFNESS 93 0.0011
648 NASAL CONGESTION 62 0.0011
649 UPPER LIMB FRACTURE 21 0.0011
650 CARDIO-RESPIRATORY ARREST 44 0.0011
651 DYSGEUSIA 78 0.0010
652 MUSCLE TIGHTNESS 17 0.0010
653 MYALGIA 178 0.0010
654 CYTOKINE RELEASE SYNDROME 21 0.0010
655 INFLAMMATION 54 0.0010
656 AGEUSIA 26 0.0010
657 FULL BLOOD COUNT DECREASED 21 0.0010
658 POST PROCEDURAL COMPLICATION 20 0.0010
659 DRUG PRESCRIBING ERROR 20 0.0010
660 FULL BLOOD COUNT ABNORMAL 11 0.0010
661 AFFECT LABILITY 10 0.0010
662 METASTASES TO LUNG 12 0.0010
663 PAIN IN EXTREMITY 306 0.0010
664 THYROID DISORDER 16 0.0010
665 DYSARTHRIA 39 0.0010
666 FEEDING DISORDER 21 0.0010
667 DELUSION 16 0.0010
668 PALLOR 28 0.0010
669 ABDOMINAL PAIN LOWER 26 0.0010
670 INJECTION SITE MASS 38 0.0010
671 ORAL PAIN 23 0.0010
672 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 185 0.0010
673 CARDIAC DISORDER 96 0.0010
674 COAGULOPATHY 17 0.0010
675 BACTERIAL INFECTION 19 0.0010
676 PROSTATIC SPECIFIC ANTIGEN INCREASED 14 0.0010
677 LOSS OF CONSCIOUSNESS 130 0.0010
678 TREMOR 168 0.0010
679 WHITE BLOOD CELL COUNT DECREASED 109 0.0010
680 ACCIDENT 12 0.0010
681 BRONCHITIS 74 0.0010
682 FEELING JITTERY 19 0.0010
683 URTICARIA 167 0.0010
684 UPPER RESPIRATORY TRACT INFECTION 46 0.0010
685 FOOT DEFORMITY 11 0.0010
686 ECONOMIC PROBLEM 15 0.0010
687 GAIT INABILITY 33 0.0010
688 GLAUCOMA 19 0.0010
689 NECK PAIN 55 0.0010
690 BURNING SENSATION 69 0.0010
691 SWELLING FACE 64 0.0010
692 CEREBRAL HAEMORRHAGE 35 0.0010
693 EAR INFECTION 26 0.0010
694 METASTASES TO LIVER 17 0.0010
695 CYST 12 0.0010
696 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
697 PULMONARY ARTERIAL HYPERTENSION 14 0.0010
698 THROAT TIGHTNESS 26 0.0010
699 SWOLLEN TONGUE 30 0.0010
700 APHASIA 29 0.0010
701 WEIGHT INCREASED 214 0.0010
702 DERMATITIS ALLERGIC 12 0.0010
703 KNEE ARTHROPLASTY 20 0.0009
704 SOMNOLENCE 191 0.0009
705 MUSCLE SPASMS 174 0.0009
706 SCRATCH 10 0.0009
707 HALLUCINATION, VISUAL 20 0.0009
708 PNEUMOTHORAX 15 0.0009
709 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 67 0.0009
710 OBESITY 15 0.0009
711 DIVERTICULITIS 26 0.0009
712 BREAST PAIN 10 0.0009
713 ECZEMA 49 0.0009
714 ORAL DISCOMFORT 13 0.0009
715 MUSCULOSKELETAL PAIN 49 0.0009
716 THROMBOSIS 75 0.0009
717 HAEMOPTYSIS 26 0.0009
718 HERNIA 18 0.0009
719 HYPOAESTHESIA ORAL 14 0.0009
720 LIVER FUNCTION TEST ABNORMAL 27 0.0009
721 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
722 ILL-DEFINED DISORDER 56 0.0009
723 THROMBOCYTOPENIA 103 0.0009
724 GENERAL PHYSICAL HEALTH DETERIORATION 106 0.0009
725 LABORATORY TEST ABNORMAL 27 0.0009
726 DYSPEPSIA 90 0.0009
727 SLEEP DISORDER 64 0.0009
728 TENDONITIS 14 0.0009
729 VISUAL ACUITY REDUCED 30 0.0009
730 HYPERTENSIVE CRISIS 10 0.0009
731 LIVER INJURY 22 0.0009
732 ILLNESS 92 0.0009
733 DYSPHONIA 52 0.0009
734 PRODUCT USE ISSUE 167 0.0009
735 HAEMATOCHEZIA 49 0.0009
736 EYE INFECTION 10 0.0009
737 LIVER FUNCTION TEST INCREASED 19 0.0009
738 NEUTROPHIL COUNT DECREASED 36 0.0009
739 POOR QUALITY SLEEP 19 0.0009
740 BALANCE DISORDER 76 0.0009
741 ARTHRITIS 69 0.0009
742 SKIN HAEMORRHAGE 13 0.0009
743 SCAB 10 0.0009
744 PERIPHERAL COLDNESS 12 0.0009
745 HEPATIC CANCER 21 0.0009
746 PULMONARY EMBOLISM 83 0.0009
747 HIP FRACTURE 28 0.0009
748 DEPRESSED MOOD 46 0.0009
749 INFLUENZA 97 0.0009
750 PERITONITIS 18 0.0009
751 SINUSITIS 89 0.0009
752 SWELLING 81 0.0009
753 EYELID OEDEMA 10 0.0009
754 MASS 12 0.0009
755 OSTEOPENIA 13 0.0009
756 HEART RATE DECREASED 30 0.0009
757 MOUTH ULCERATION 18 0.0009
758 DRY MOUTH 69 0.0008
759 VISION BLURRED 116 0.0008
760 HYPOAESTHESIA 126 0.0008
761 VIRAL INFECTION 28 0.0008
762 LYMPHOMA 13 0.0008
763 INCREASED APPETITE 16 0.0008
764 DYSKINESIA 34 0.0008
765 CARDIOGENIC SHOCK 12 0.0008
766 UNDERDOSE 61 0.0008
767 LIVER DISORDER 37 0.0008
768 FACE OEDEMA 14 0.0008
769 MYELODYSPLASTIC SYNDROME 12 0.0008
770 CANDIDA INFECTION 14 0.0008
771 HYPERTHYROIDISM 12 0.0008
772 CONDITION AGGRAVATED 252 0.0008
773 TOOTHACHE 15 0.0008
774 HYPOKINESIA 12 0.0008
775 INTENTIONAL OVERDOSE 53 0.0008
776 STOMATITIS 50 0.0008
777 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
778 SCHIZOPHRENIA 10 0.0008
779 LUNG DISORDER 40 0.0008
780 ALANINE AMINOTRANSFERASE INCREASED 50 0.0008
781 DERMATITIS 17 0.0008
782 SINUS DISORDER 16 0.0008
783 NASOPHARYNGITIS 148 0.0008
784 FOOT FRACTURE 15 0.0008
785 PRODUCT AVAILABILITY ISSUE 18 0.0008
786 STAPHYLOCOCCAL INFECTION 26 0.0008
787 INFECTION 114 0.0008
788 CARPAL TUNNEL SYNDROME 11 0.0008
789 LOWER LIMB FRACTURE 15 0.0008
790 THERAPY CESSATION 40 0.0008
791 INFUSION SITE PAIN 10 0.0008
792 FEMUR FRACTURE 24 0.0008
793 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 37 0.0008
794 PANCYTOPENIA 43 0.0008
795 PLASMA CELL MYELOMA 30 0.0008
796 HYPERSOMNIA 22 0.0008
797 PLATELET COUNT INCREASED 10 0.0008
798 HERPES ZOSTER 44 0.0008
799 ACCIDENTAL OVERDOSE 28 0.0008
800 ROAD TRAFFIC ACCIDENT 32 0.0008
801 ACCIDENTAL UNDERDOSE 11 0.0008
802 RESPIRATORY DISTRESS 21 0.0008
803 LEUKOPENIA 38 0.0008
804 ANKYLOSING SPONDYLITIS 10 0.0008
805 THERAPEUTIC RESPONSE UNEXPECTED 34 0.0008
806 SARS-COV-2 TEST POSITIVE 10 0.0008
807 ERYTHEMA 155 0.0008
808 PRESCRIBED UNDERDOSE 15 0.0008
809 HYPOTHYROIDISM 24 0.0008
810 SKIN EXFOLIATION 63 0.0007
811 MALIGNANT MELANOMA 10 0.0007
812 IRRITABLE BOWEL SYNDROME 16 0.0007
813 RASH MACULAR 26 0.0007
814 UNEVALUABLE EVENT 56 0.0007
815 COLITIS 28 0.0007
816 BLOOD URINE PRESENT 14 0.0007
817 PARAESTHESIA 116 0.0007
818 BLADDER CANCER 43 0.0007
819 PULMONARY FIBROSIS 14 0.0007
820 NERVOUSNESS 38 0.0007
821 DISEASE PROGRESSION 86 0.0007
822 ANHEDONIA 19 0.0007
823 DRUG ABUSE 60 0.0007
824 CONTUSION 69 0.0007
825 OCULAR HYPERAEMIA 34 0.0007
826 DRUG INTOLERANCE 69 0.0007
827 SKIN REACTION 10 0.0007
828 EYE PAIN 40 0.0007
829 LYMPHOPENIA 10 0.0007
830 DISORIENTATION 28 0.0007
831 DISCOMFORT 43 0.0007
832 CIRCULATORY COLLAPSE 12 0.0007
833 NEOPLASM MALIGNANT 47 0.0007
834 FREQUENT BOWEL MOVEMENTS 19 0.0007
835 HYPERSENSITIVITY 130 0.0007
836 PARALYSIS 10 0.0007
837 MOOD ALTERED 19 0.0007
838 PRODUCT DISPENSING ERROR 15 0.0007
839 FLUID OVERLOAD 10 0.0007
840 MALIGNANT NEOPLASM PROGRESSION 69 0.0007
841 HEPATOTOXICITY 15 0.0007
842 GASTRIC DISORDER 23 0.0007
843 CARDIOVASCULAR DISORDER 17 0.0007
844 SPEECH DISORDER 35 0.0007
845 DEATH 575 0.0007
846 HEPATITIS 17 0.0007
847 LACRIMATION INCREASED 20 0.0007
848 BONE DISORDER 12 0.0007
849 LUNG NEOPLASM MALIGNANT 27 0.0007
850 ASTHMA 74 0.0007
851 HEMIPARESIS 11 0.0006
852 FEELING COLD 18 0.0006
853 BASAL CELL CARCINOMA 10 0.0006
854 SEIZURE 74 0.0006
855 EYE DISORDER 21 0.0006
856 PARANOIA 11 0.0006
857 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
858 BONE PAIN 37 0.0006
859 ABNORMAL BEHAVIOUR 25 0.0006
860 MUSCULOSKELETAL DISORDER 12 0.0006
861 THERAPY INTERRUPTED 45 0.0006
862 DRUG DOSE OMISSION 103 0.0006
863 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
864 EAR PAIN 12 0.0006
865 DEAFNESS 16 0.0006
866 NIGHTMARE 21 0.0006
867 DISABILITY 12 0.0006
868 BONE DENSITY DECREASED 19 0.0006
869 PELVIC PAIN 11 0.0006
870 SKIN CANCER 13 0.0006
871 PAIN IN JAW 17 0.0006
872 HOSPITALISATION 92 0.0006
873 PRODUCT PRESCRIBING ISSUE 13 0.0006
874 EXTRA DOSE ADMINISTERED 24 0.0006
875 EYE SWELLING 22 0.0006
876 FEELING HOT 36 0.0006
877 HEPATIC ENZYME INCREASED 40 0.0006
878 TREATMENT NONCOMPLIANCE 32 0.0006
879 DEEP VEIN THROMBOSIS 38 0.0006
880 DEPRESSION 133 0.0006
881 HAEMORRHAGE 61 0.0006
882 FRACTURE 11 0.0006
883 NEUTROPENIA 79 0.0006
884 GLOSSODYNIA 13 0.0006
885 NERVOUS SYSTEM DISORDER 18 0.0006
886 ABASIA 14 0.0006
887 RENAL FAILURE ACUTE 24 0.0006
888 IRRITABILITY 34 0.0006
889 CHOKING 11 0.0006
890 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 13 0.0006
891 MYELOSUPPRESSION 20 0.0006
892 PRODUCT DOSE OMISSION 36 0.0006
893 NEOPLASM PROGRESSION 19 0.0005
894 ERECTILE DYSFUNCTION 14 0.0005
895 PRODUCT ADMINISTRATION ERROR 11 0.0005
896 ABNORMAL DREAMS 15 0.0005
897 ANAPHYLACTIC REACTION 30 0.0005
898 TOOTH DISORDER 12 0.0005
899 INFLUENZA LIKE ILLNESS 44 0.0005
900 SEDATION 14 0.0005
901 PHOTOPHOBIA 10 0.0005
902 HOT FLUSH 40 0.0005
903 CHILLS 62 0.0005
904 SUICIDE ATTEMPT 32 0.0005
905 DRUG INEFFECTIVE 682 0.0005
906 PSORIATIC ARTHROPATHY 21 0.0005
907 DYSTONIA 10 0.0005
908 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 36 0.0005
909 AGITATION 37 0.0005
910 AGGRESSION 25 0.0005
911 INCORRECT DOSE ADMINISTERED BY DEVICE 13 0.0005
912 TRANSAMINASES INCREASED 11 0.0005
913 NEURALGIA 12 0.0005
914 COLITIS ULCERATIVE 22 0.0005
915 INTENTIONAL DOSE OMISSION 14 0.0005
916 SNEEZING 11 0.0005
917 THROAT IRRITATION 22 0.0005
918 OVERDOSE 105 0.0005
919 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 98 0.0005
920 LYMPHADENOPATHY 17 0.0005
921 GASTRIC CANCER 12 0.0005
922 EYE IRRITATION 27 0.0005
923 DRUG EFFECT INCOMPLETE 17 0.0005
924 RESPIRATORY DISORDER 14 0.0005
925 INCORRECT DOSE ADMINISTERED 106 0.0005
926 PRODUCT QUALITY ISSUE 63 0.0005
927 PRODUCT DOSE OMISSION ISSUE 136 0.0005
928 IMPAIRED HEALING 15 0.0005
929 DRUG ADMINISTRATION ERROR 14 0.0005
930 INJECTION SITE HAEMORRHAGE 36 0.0005
931 INJECTION SITE PRURITUS 30 0.0004
932 COMPLETED SUICIDE 37 0.0004
933 INJECTION SITE SWELLING 34 0.0004
934 ANGER 15 0.0004
935 SURGERY 26 0.0004
936 INJURY 31 0.0004
937 PSYCHOTIC DISORDER 13 0.0004
938 MENTAL DISORDER 19 0.0004
939 MENTAL STATUS CHANGES 12 0.0004
940 THERAPEUTIC RESPONSE DECREASED 26 0.0004
941 PRODUCT USE IN UNAPPROVED INDICATION 106 0.0004
942 INJECTION SITE PAIN 130 0.0004
943 JOINT STIFFNESS 11 0.0004
944 RHEUMATOID ARTHRITIS 47 0.0004
945 FIBROMYALGIA 10 0.0004
946 FEAR 11 0.0004
947 MOOD SWINGS 13 0.0004
948 EXTRAPYRAMIDAL DISORDER 10 0.0004
949 DRY EYE 20 0.0004
950 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
951 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
952 CRYING 14 0.0004
953 RESTLESSNESS 14 0.0004
954 DISEASE RECURRENCE 18 0.0004
955 THERAPY NON-RESPONDER 17 0.0004
956 COMA 18 0.0004
957 ARTHROPATHY 21 0.0004
958 OSTEONECROSIS 12 0.0004
959 RESPIRATORY ARREST 10 0.0004
960 PSORIASIS 47 0.0004
961 EPILEPSY 11 0.0004
962 RENAL CANCER 17 0.0004
963 DEVICE ISSUE 32 0.0004
964 BREAST CANCER 33 0.0004
965 NIGHT SWEATS 11 0.0003
966 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
967 EMOTIONAL DISORDER 10 0.0003
968 DEVICE LEAKAGE 14 0.0003
969 FLUSHING 32 0.0003
970 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
971 INJECTION SITE ERYTHEMA 37 0.0003
972 INJECTION SITE BRUISING 23 0.0003
973 ADVERSE EVENT 26 0.0003
974 VAGINAL HAEMORRHAGE 12 0.0003
975 PROSTATE CANCER 22 0.0003
976 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
977 EMOTIONAL DISTRESS 31 0.0003
978 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 11 0.0002
979 DRUG EFFECT DECREASED 12 0.0002
980 PRODUCT SUBSTITUTION ISSUE 12 0.0002
981 INFUSION RELATED REACTION 13 0.0002
982 SKIN BURNING SENSATION 14 0.0002
983 DEVICE MALFUNCTION 13 0.0002
984 NO ADVERSE EVENT 31 0.0002
985 TREATMENT FAILURE 14 0.0002
986 PRODUCT STORAGE ERROR 14 0.0002
987 INJECTION SITE REACTION 11 0.0002
988 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
989 SUICIDAL IDEATION 13 0.0001
990 DRUG DEPENDENCE 17 0.0001